Apnimed, Inc. (APMD)

NASDAQ: APMD · Real-Time Price · USD

22.85

-1.05 (-4.41%)

Sep 30, 2026, 11:06 AM EDT - Market open

Apnimed Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	115.12	38.47	8.01	-	1
Revenue Growth	-	380.12%	-	-	-
Gross Profit	108.1	31.77	4.64	-	1
Operating Income	35.87	-53.82	-114.23	-48.52	-26.55
Net Income	163.58	-128.19	-111.31	-80.25	-26.21
Earnings Per Share	8.49	-23.76	-20.73	-27.84	-11.04
EPS Growth	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	172.8	41.89	68.35	173.96	133.83
Total Debt	80.35	41.52	1.1	-	0.11
Net Cash (Debt)	92.46	0.37	67.26	173.96	133.72
Net Cash Growth	-46.85%	-99.45%	-61.34%	30.09%	-
Net Cash Per Share	4.84	0.07	12.52	60.35	56.31

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-69.94	-77.83	-110.21	25.41	-26.13
Capital Expenditures	-	-	-0.07	-0.05	-
Free Cash Flow	-69.94	-77.83	-110.28	25.37	-26.13
Free Cash Flow Growth	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	93.90%	82.60%	57.95%	-	100.00%
Operating Margin	31.16%	-139.91%	-1425.79%	-	-2654.80%
Pretax Margin	148.32%	-150.91%	-1354.84%	-	-2620.80%
Profit Margin	142.10%	-333.25%	-1389.23%	-	-2620.80%
FCF Margin	-60.75%	-202.33%	-1376.42%	-	-2612.90%